the annexin 1 peptide, ac2-26 (Bio Basic Canada)
90
Structured Review
Bio Basic Canada
the annexin 1 peptide, ac2-26
The Annexin 1 Peptide, Ac2 26, supplied by Bio Basic Canada, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+annexin+1+peptide%2C+ac2-26/the+annexin+1+peptide++ac2+26/pm20733322-45-4-9
Average 90 stars, based on 1 article reviews
The Annexin 1 Peptide, Ac2 26, supplied by Bio Basic Canada, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+annexin+1+peptide%2C+ac2-26/the+annexin+1+peptide++ac2+26/pm20733322-45-4-9
Average 90 stars, based on 1 article reviews
the annexin 1 peptide, ac2-26 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Produced:Article Title: Annexin 1-derived peptide Ac2-26 inhibits eosinophil recruitment in vivo via decreasing prostaglandin D₂. Article Snippet: Background: Asthma is a chronic inflammatory disease of the mucosa and is associated with excess TH 2 cytokines, eotaxin, prostaglandin D 2 (PGD 2 ) and eosinophilia in the lungs.. Previous studies have emphasized that the N-terminal peptide of annexin 1 (peptide Ac2-26) can inhibit mast cell degranulation, antigen-induced eotaxin release as well as the accumulation of both neutrophils and eosinophils in a model of rat pleurisy.. The purpose of this study was to demonstrate anti-asthmatic effects of Ac2-26 in an asthma model and to explore possible mechanisms involved. High Performance Liquid Chromatography:Article Title: Annexin 1-derived peptide Ac2-26 inhibits eosinophil recruitment in vivo via decreasing prostaglandin D₂. Article Snippet: Background: Asthma is a chronic inflammatory disease of the mucosa and is associated with excess TH 2 cytokines, eotaxin, prostaglandin D 2 (PGD 2 ) and eosinophilia in the lungs.. Previous studies have emphasized that the N-terminal peptide of annexin 1 (peptide Ac2-26) can inhibit mast cell degranulation, antigen-induced eotaxin release as well as the accumulation of both neutrophils and eosinophils in a model of rat pleurisy.. The purpose of this study was to demonstrate anti-asthmatic effects of Ac2-26 in an asthma model and to explore possible mechanisms involved. |